Miguel Rebollar
Internal Medicine · Hialeah, FLNPI 1831108729
Payments from drug & device makers
Across 235 payments — averaging $2332.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sage Therapeutics, LLC$388K
- Novo Nordisk AS$155K
- Esperion Therapeutics, Inc.$916
- Novartis$528
- Amgen$493
- AbbVie$481
- plus $3K from 19 others
What the payments were for
- Food & beverage$5,133100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sage Therapeutics, LLC | 30 | $388,103 |
| Novo Nordisk AS | 136 | $154,903 |
| Esperion Therapeutics, Inc. | 7 | $916 |
| Novartis | 7 | $528 |
| Amgen | 5 | $493 |
| AbbVie(2 entities) | 9 | $481 |
| Johnson & Johnson | 3 | $349 |
| Kyowa Kirin, Inc. | 7 | $319 |
| Lilly USA, LLC | 5 | $265 |
| Sanofi-aventis U.S. LLC | 2 | $247 |
| Amarin Pharma, Inc. | 5 | $236 |
| Boston Scientific | 1 | $166 |
| Medtronic | 1 | $164 |
| Abbott | 1 | $132 |
| AstraZeneca | 2 | $130 |
| Edwards Lifesciences | 1 | $125 |
| Novo Nordisk | 1 | $116 |
| Astellas Pharma US Inc | 1 | $112 |
| Ambu Inc. | 1 | $101 |
| Lundbeck LLC | 3 | $87 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Philips North America LLC | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 1 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXLIZET$916
- NEXLETOL$916
- ENTRESTO$468
- XARELTO$349
- VRAYLAR$250
- PRALUENT$247
- AIMOVIG$227
- NOURIANZ$225
- WATCHMAN Access System$166
- SYMPLICITY G3$164
- Mitra Clip system$132
- Edwards SAPIEN 3 Transcatheter Heart Valve$125
- Vascepa$125
- Repatha$125
- Prolia$125
- MOUNJARO$118
- RYBELSUS$116
- MYRBETRIQ$112
How this compares
$548,157 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 82 | $58,370 |
| EliquisApixaban | 54 | $35,367 |
| OzempicSemaglutide | 33 | $33,702 |
| MounjaroTirzepatide | 21 | $24,770 |
| JanuviaSitagliptin Phosphate | 23 | $23,863 |
| JardianceEmpagliflozin | 13 | $18,481 |
| JanumetSitagliptin Phos/Metformin Hcl | 13 | $18,436 |
| LinzessLinaclotide | 32 | $17,490 |
| EntrestoSacubitril/Valsartan | 22 | $16,467 |
| MyrbetriqMirabegron | 20 | $8,994 |
| Tadalafil | 30 | $8,967 |
| CreonLipase/Protease/Amylase | 18 | $7,707 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $4,446 |
| LumiganBimatoprost | 13 | $4,199 |
| LivaloPitavastatin Calcium | 13 | $4,089 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $130 | $58,37082 claims |
| Novo NordiskOzempic | $116 | $33,70233 claims |
| AbbVieLinzess, Creon, Lumigan | $481 | $29,39763 claims |
| Lilly USA, LLCMounjaro | $265 | $24,77021 claims |
| NovartisEntresto | $528 | $16,46722 claims |
| Astellas Pharma US IncMyrbetriq | $112 | $8,99420 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $20 | $4,08913 claims |
| Sanofi-aventis U.S. LLCLantus | $247 | $1,98828 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Hialeah
- Gilberto JimenezHialeah$35.6M
- William SanchezHialeah$28.9M
- Jorge DiazHialeah$20.7M
- Francisco BautistaHialeah$19.1M
- Karelia RuizHialeah$7.7M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Mira BaronWest Palm Beach$29.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.